COMMUNIQUÉS West-GlobeNewswire

Epizyme to Present at the Jefferies 2017 London Healthcare Conference
09/11/2017
CAMBRIDGE, Mass., Nov. 09, 2017 (GLOBE NEWSWIRE) -- Epizyme, Inc. (NASDAQ: EPZM ), a clinical-stage biopharmaceutical company creating novel epigenetic therapies, today announced that management will present a company [...]
INC Research/inVentiv Health Reports Third Quarter 2017 Results
09/11/2017
Highlights Net service revenue of $592.2 million and $1,102.4 million for the three and nine months ended September 30, 2017, respectively. Combined Company adjusted net service revenue of $766.6 million and $2,331.6 [...]
Quotient Limited to Participate in the Jefferies 2017 London Healthcare Conference
09/11/2017
JERSEY, Channel Islands, Nov. 09, 2017 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ: QTNT ), a commercial-stage diagnostics company, today announced that the Company's Chairman and Chief Executive Officer, Paul Cowan, [...]
iSalus Healthcare Opens New Office in Downtown Indianapolis
09/11/2017
INDIANAPOLIS, Nov. 09, 2017 (GLOBE NEWSWIRE) -- iSalus Healthcare, a premier healthcare technology and services company in Indiana, has recently moved offices to 1 Virginia Avenue, Suite 500, Indianapolis, IN 46204 . [...]
Helius Medical Technologies Announces Positive Results from its Registrational Clinical Trial for Traumatic Brain Injury (TBI)
09/11/2017
NEWTOWN, Pa., Nov. 09, 2017 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (TSX: HSM ) (OTCQB:HSDT) ("Helius" or the "Company"), a medical technology company focused on neurological wellness, announced results [...]
RadNet Reports Third Quarter Financial Results and Reaffirms Previously Announced 2017 Guidance Levels
09/11/2017
Total Net Revenue (“Revenue”) increased 1.3% to $227.6 million in the third quarter of 2017 from $224.6 million in the third quarter of 2016: Adjusting for the sale of the Rhode Island facilities, Revenue increased 1.9 [...]
Crown Bioscience Inc. Announcing the 2017 Board of Directors Election Results
09/11/2017
TAIPEI, Taiwan, Nov. 09, 2017 (GLOBE NEWSWIRE) -- Crown Bioscience, a wholly-owned subsidiary of Crown Bioscience International (TWSE: ticker 6554) and a global drug discovery and development services company providing [...]
Ossur Hf : Management Changes
09/11/2017
Announcement Össur hf. No. 81/2017 Reykjavik, 9 November 2017 New R&D leadership Dr. Thorvaldur Ingvarsson, EVP of Research & Development (R&D), has decided to leave Össur after leading the R&D function [...]
Share Capital and Votes
09/11/2017
Pursuant to section 10 of executive order no. 1526 of December 9, 2016 on Issuers' Disclosure Obligations, it is hereby announced, that BioPorto A/S total share capital amounts to DKK 155.509.681 divided into shares of [...]
Bavarian Nordic Announces Initiation of Phase 2 Booster Study of its Universal RSV Vaccine
09/11/2017
Study to help determine if MVA-BN RSV will be administered as a seasonal vaccine or if a single shot is effective for multiple seasons COPENHAGEN, Denmark, November 9, 2017 - Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) [...]
VALNEVA publie une très forte performance opérationnelle sur les neufs premiers mois de l'exercice 2017
09/11/2017
Valneva publie une très forte performance opérationnelle sur les neufs premiers mois de l'exercice 2017 La forte performance opérationnelle sur les neuf premiers mois de l'exercice 2017 et les perspectives annuelles [...]
VALNEVA Reports Strong Operational Performance for the First Nine Months of 2017
09/11/2017
Valneva Reports Strong Operational Performance for the First Nine Months of 2017 Strong financial performance for first nine months of 2017 and full year outlook leads to upward revision of EBITDA guidance Total [...]
ABLYNX TO PRESENT AT UPCOMING INVESTOR CONFERENCES IN LONDON AND PARIS
09/11/2017
GHENT, Belgium, 9 November 2017 - Ablynx [Euronext Brussels and Nasdaq: ABLX] today announces that it will participate in the following upcoming investor conferences taking place in London, UK and Paris, France: [...]
Apellis Pharmaceuticals Announces Pricing of Initial Public Offering
09/11/2017
CRESTWOOD, Ky., Nov. 08, 2017 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (NASDAQ: APLS ), a clinical-stage biopharmaceutical company focused on the development of novel therapeutic compounds to treat disease [...]
Sarepta Therapeutics Prices $475 Million of Convertible Senior Notes Due 2024
09/11/2017
CAMBRIDGE, Mass., Nov. 08, 2017 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ: SRPT ), a commercial-stage biopharmaceutical company focused on the discovery and development of precision genetic medicines to [...]
Telix Pharmaceuticals Limited Successfully Completes $50 Million Oversubscribed Initial Public Offering
09/11/2017
MELBOURNE, Australia, Nov. 09, 2017 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (“Telix”, the “Company”), an Australian biopharmaceutical company focused on the development of diagnostic and therapeutic products [...]
New Eftilagimod Alpha (LAG-3Ig or IMP321) Data for Presentation at the Society for Immunotherapy of Cancer (SITC) 2017 Annual Meeting
08/11/2017
SYDNEY, Australia, Nov. 08, 2017 (GLOBE NEWSWIRE) -- Prima BioMed Ltd (ASX:PRR) (NASDAQ: PBMD ) (“Prima”) is pleased to announce the presentation of new data from its TACTI-mel Phase I clinical trial in Australia [...]
Cocrystal Pharma Announces Filing 2017 Third Quarter Financial Statements and Provides Company Update
08/11/2017
ATLANTA, GA and BOTHELL, WA, Nov. 08, 2017 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (OTCQB: COCP), a company focused on developing novel antiviral therapeutics for human diseases, today announced the filing of its [...]
Atrion Corporation Declares Quarterly Cash Dividend
08/11/2017
ALLEN, Texas, Nov. 08, 2017 (GLOBE NEWSWIRE) -- Atrion Corporation (Nasdaq: ATRI ) today announced that its Board of Directors declared a quarterly cash dividend of $1.20 per share on the Company’s outstanding Common [...]

Pages